Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03116009Phase 3Terminated
Phase 3, randomised, open-label trial (2 arms), sponsored by University of Illinois Chicago. Primary endpoint: Large for gestational age or macrosomia. Started Mar 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03116009.